PARD (Poniard Pharmaceuticals) Common Stock: $1.20 Mil (As of Sep. 2011)


What is Poniard Pharmaceuticals Common Stock?

Poniard Pharmaceuticals PARD Common Stock is $1.20 Mil as of Sep. 2011.

Poniard Pharmaceuticals's quarterly common stock increased from Mar. 2011 ($1.18 Mil) to Jun. 2011 ($1.20 Mil) and increased from Jun. 2011 ($1.20 Mil) to Sep. 2011 ($1.20 Mil).

Poniard Pharmaceuticals's annual common stock increased from Dec. 2008 ($0.69 Mil) to Dec. 2009 ($0.84 Mil) and increased from Dec. 2009 ($0.84 Mil) to Dec. 2010 ($0.97 Mil).

Poniard Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Common Stock Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.69 0.69 0.84 0.97

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.97 1.18 1.20 1.20

Poniard Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $1.20 Mil mean?
Poniard Pharmaceuticals (PARD) has a Common Stock of $1.20 Mil as of Sep. 2011. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Common Stock too high?
Poniard Pharmaceuticals' current Common Stock is $1.20 Mil.
How does Poniard Pharmaceuticals' Common Stock compare to OBMP and NSPX?
Poniard Pharmaceuticals' Common Stock of $1.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Common Stock is $1.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Common Stock of $1.20 Mil. The current Common Stock is $1.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Common Stock is $1.20 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.